The fully randomized placebo-controlled trial, conducted by Moore Clinical Research, an independent FDA-compliant contract research organization (CRO), compares the performance of HSRx’s acne treatment product with that of
Retinitis pigmentosa leads to the progressive degeneration of rod and cone photoreceptors (cells found in the retina that sense light), resulting in severe vision loss and blindness. With
Talazoparib is currently in a Phase III trial designed to treat patients with deleterious germline BRCA 1 or BRCA 2 mutations and locally advanced and/or metastatic breast cancer.
Bavituximab is Peregrine’s investigational phosphatidylserine (PS)-signalling pathway inhibitor and durvalumab is AstraZeneca’s investigational anti-PD-L1 immune checkpoint inhibitor, while both are investigational immunotherapies with different mechanisms that assist the
The Dickkopf-3 gene produces a protein called Reduced Expression in Immortalized Cells protein (REIC), which is vital in the downstream mechanism of apoptosis and when absent cancer cells
The PDC platform has showed highly selective cancer targeting both preclinically in more than 60 in vivo cancer models, and subsequently confirmed clinically in over ten cancer types.
Currently, SER-109 is being examined as a new therapeutic modality to treat recurrent CDI by correcting a dysbiosis of the human microbiome, which is an underlying cause of
In July, ixazomib was granted accelerated assessment by the EMA’s Committee for Medicinal Products for Human Use (CHMP). The MAA was based on the results of the first
Eteplirsen is designed to address the underlying cause of DMD by allowing the production of a functional dystrophin protein. The company said that data from clinical trials of
Ofatumumab, a fully human monoclonal antibody currently being designed for relapsing remitting multiple sclerosis (RRMS) and other autoimmune indications, targets CD20 and is administered by subcutaneous injection. Previously,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.